Back
ditki Logo
medical & biological sciences
All Access Pass - 1 FREE Month!
Institutional email required, no credit card necessary.
Asthma
Free One-Month! Institutional (.edu or .org) email required
Log in or start your One-Week Free Trial!

Asthma

Asthma
Overview
What is asthma?
Asthma is a heterogeneous chronic disease of the conducting airways that is characterized by intermittent and mostly reversible periods of bronchial obstruction, with bronchial hyper-reactivity, excessive mucus, and airway remodeling. In contrast, recall that COPD is characterized by constant, irreversible airway obstruction.
What are some key symptoms?
Asthmatic patients experience episodes of cough, wheezing, dyspnea, and feelings of chest tightness.
What are some key PFT findings?
It is characterized by increased total lung capacity because air is trapped in the lungs. The ratio of forced expiratory volume in one second to forced vital capacity (FEV1/FVC) is normal or low.
What happens with DLCO and V/Q in asthma?
The diffusing capacity of the lungs for carbon monoxide (DLCO) is normal or elevated. Ventilation to perfusion mismatches occur, which can lead to hypoxemia.
What are key ways to diagnose asthma?
Diagnosis of asthma can include: pulmonary function tests (spirometry), methacholine bronchial challenge tests, and allergy tests.
Asthma Classification
What is meant by eosinophilic asthma with high levels of type-2 inflammation (type-2 high asthma)?
This group includes the most thoroughly studied subtypes of asthma. Type-2 inflammation is due to an imbalance towards T-helper 2 cells and Type-2 innate lymphoid cells and their cytokines (specifically, IL-4, IL-5, and IL-13) which promote IgE production from B cells. Importantly, this class of asthma responds better to steroids than type-2 low inflammation (discussed later).
Describe key type-2 high asthma subtypes
Early Onset with Allergy
  • Because allergens are the triggers for asthma attacks, this subtype is sometimes called "extrinsic asthma."
  • Asthma attacks are IgE-mediated, and patients often have other allergies and history of rhinitis and atopic dermatitis. Click to review Hypersensitivity Type 1
  • It tends to be familial, is associated with early childhood respiratory viral infections (especially RSV and rhinovirus), and, is most common in boys.
  • Biomarkers include elevated eosinophils and serum IgE.
  • Common triggers include house dust mites, mold, pets, and pollen.
Late-onset without atopy
  • Patients have fewer allergies, but often present with more severe asthma.
Often co-exists with chronic rhinosinusitis and nasal polyps*.
  • Not familial, and tends to occur most often in adult females.
Biomarkers include elevated eosinophils, and, in a sub-set of patients, elevated levels of Staphylococcus aureusendotoxin-specific IgE.*
  • Be aware that, although most patients do not have elevated levels of IgE, it is thought that localized IgE in the airways occurs.
  • Key triggers in this group include air pollution, especially diesel gas fumes and other irritants, as well as respiratory infections.
Aspirin-exacerbated asthma (aka, aspirin-exacerbated respiratory disease - AERD)
  • Form of asthma triggered by aspirin – it is often severe, and typically occurs in adults
    • Thus, some consider this to be a sub-sub-type of late-onset asthma.
  • Aspirin-exacerbated asthma is due genetic abnormalities that lead to dysregulation of arachidonic acid metabolism.
What is meant by neutrophilic, with low levels of type-2 inflammation (type-2 low asthma)?
As a class, type-2-low asthma does not respond as well to corticosteroids because it has low levels of type 2 inflammation (the same is true for mixed and pauci-granuloctyic asthma).
Describe different type-2 low asthma subtypes
Neutrophilic asthma Characterized by elevated levels of the cytokine IL-17 and oxidative stress.
  • Usually adult-onset and often severe.
  • As mentioned, it is resistant to corticosteroids.
Key at-risk populations include: smokers, obese people, and elderly people.*
Mixed granulocytic asthma
  • Characterized by elevated levels of T helper 2 (TH2) and T helper 17 (TH17) cytokines.
Paucigranulocytic asthma
  • Characterized by non-inflammatory (or low inflammatory) changes in the bronchi: remodeling and hyper-reactivity.
What are some additional types of asthma?
Two additional asthma phenotypes that can overlap with those already listed:
Occupational, aka, work-related asthma
  • Develops in response to exposure to workplace allergens or irritants (and, because it is occupation-related, tends to develop in adulthood).
Exercise-induced/exacerbated asthma
  • Triggered by exercise.
  • Although the exact mechanisms are unclear, it is thought that exercise-related evaporation and water loss from the airway epithelia causes injury that leads to upregulation of pro-inflammatory mediators.
Asthma histopathology
What are key general pathologic features of asthma?
  • Smooth muscle overgrowth, which contributes to hyper-reactivity and constriction of the airways.
  • Possible inflammation and fibrosis with migration of eosinophils and/or neutrophils in the wall of the airway (depending on the type of asthma).
  • The basement membrane is thickened.
  • Respiratory epithelium displays goblet cell metaplasia.
  • Excess mucus further narrowing the airway so that the lumen is much smaller than normal.
What are some histopathological hallmarks of asthma?
  • Curschmann spirals are mucus plugs that comprise desquamated airway epithelial cells.
  • Charcot-Leyden Crystals are crystals formed from eosinophil proteins.
Treatments
For a clinical review of treatment, see: Step-wise approach to treatment
In short:
  • Short-acting beta-antagonists, such as albuterol, are provide for quick relief during asthma attacks; they relax the smooth muscle lining the bronchi.
  • Long-acting beta-antagonists, such as salmeterol, may be used longer-term in conjunction with other drugs.
  • Inhaled corticosteroids, such as beclomethasone, suppress airway inflammation and are first-line therapy for long-term asthma management.
  • Leukotriene antagonists, such as montelukast, also reduce bronchoconstriction and inflammation, and are especially useful in exercise- and aspirin-exacerbated asthma.
  • Anticholinergics, such as ipratropium and tiotropium, produce smooth muscle relaxation in the bronchi.
  • Anti-IgE antibodies, such as Omalizumab, are effective in allergic asthma.
  • Anti-IL-5 antibodies, such as Mepolizumab, are useful in severe eosinophilic asthma.
  • Mast cell inhibitors, such as cromolyn, prevent mast cells from releasing inflammatory mediators that lead to bronchospasm.
  • Oral corticosteroids, such as prednisone, are used in severe asthma to reduce inflammation; because oral corticosteroids can have serious side effects, they are typically used for acute attacks.
References
  • Agache, I., C. Akdis, M. Jutel, and J. C. Virchow. "Untangling Asthma Phenotypes and Endotypes." Allergy 67, no. 7 (2012): 835–46. https://doi.org/10.1111/j.1398-9995.2012.02832.x.
  • Akinbami, Lara J., Alan E. Simon, and Lauren M. Rossen. "Changing Trends in Asthma Prevalence Among Children." Pediatrics 137, no. 1 (January 2016): e20152354. https://doi.org/10.1542/peds.2015-2354.
  • Arrieta, Marie-Claire, Leah T. Stiemsma, Pedro A. Dimitriu, Lisa Thorson, Shannon Russell, Sophie Yurist-Doutsch, Boris Kuzeljevic, et al. "Early Infancy Microbial and Metabolic Alterations Affect Risk of Childhood Asthma." Science Translational Medicine 7, no. 307 (September 30, 2015): 307ra152-307ra152. https://doi.org/10.1126/scitranslmed.aab2271.
  • "Asthma - Pulmonary Disorders." Merck Manuals Professional Edition. Accessed September 30, 2019. https://www.merckmanuals.com/professional/pulmonary-disorders/asthma-and-related-disorders/asthma.
  • "Asthma from Immune Pathogenesis to Precision Medicine- ClinicalKey." Accessed October 2, 2019. https://www-clinicalkey-com.proxy.medlib.uits.iu.edu/#!/content/playContent/1-s2.0-S1044532319300016?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1044532319300016%3Fshowall%3Dtrue&referrer=https:%2F%2Feuropepmc.org%2Fabstract%2Fmed%2F31387788.
  • Beasley, Richard, Alex Semprini, and Edwin A Mitchell. "Risk Factors for Asthma: Is Prevention Possible?" The Lancet 386, no. 9998 (September 2015): 1075–85. https://doi.org/10.1016/S0140-6736(15)00156-7.
  • Bro?ek, Jan L., Jean Bousquet, Ioana Agache, Arnav Agarwal, Claus Bachert, Sinthia Bosnic-Anticevich, Romina Brignardello-Petersen, et al. "Allergic Rhinitis and Its Impact on Asthma (ARIA) Guidelines—2016 Revision." Journal of Allergy and Clinical Immunology 140, no. 4 (October 2017): 950–58. https://doi.org/10.1016/j.jaci.2017.03.050.
  • Carr, Tara F., Sergejs Berdnikovs, Hans-Uwe Simon, Bruce S. Bochner, and Lanny J. Rosenwasser. "Eosinophilic
Bioactivities in Severe Asthma." World Allergy Organization Journal 9 (2016): 21. https://doi.org/10.1186/s40413-016-0112-5.
  • Carr, Tara F., Amir A. Zeki, and Monica Kraft. "Eosinophilic and Noneosinophilic Asthma." American Journal of Respiratory and Critical Care Medicine 197, no. 1 (January 2018): 22–37. https://doi.org/10.1164/rccm.201611-2232PP.
  • Chang, Hun Soo, Tae-Hyeong Lee, Ji Ae Jun, Ae Rin Baek, Jong-Sook Park, So-My Koo, Yang-Ki Kim, Ho Sung Lee, and Choon-Sik Park. "Neutrophilic Inflammation in Asthma: Mechanisms and Therapeutic Considerations." Expert Review of Respiratory Medicine 11, no. 1 (January 2, 2017): 29–40. https://doi.org/10.1080/17476348.2017.1268919.
  • Choi, Youngwoo, Youngsoo Lee, and Hae-Sim Park. "Neutrophil Activation in Occupational Asthma." Current Opinion in Allergy and Clinical Immunology 19, no. 2 (April 2019): 81. https://doi.org/10.1097/ACI.0000000000000507.
  • Choy, David F., Kevin M. Hart, Lee A. Borthwick, Aarti Shikotra, Deepti R. Nagarkar, Salman Siddiqui, Guiquan Jia, et al. "T H 2 and T H 17 Inflammatory Pathways Are Reciprocally Regulated in Asthma." Science Translational Medicine 7, no. 301 (August 19, 2015): 301ra129-301ra129. https://doi.org/10.1126/scitranslmed.aab3142.
  • "Curschmann's Spirals." In Wikipedia, June 16, 2019. https://en.wikipedia.org/w/index.php?title=Curschmann%27s_spirals&oldid=902150547.
  • Denlinger, Loren C., Brenda R. Phillips, Sima Ramratnam, Kristie Ross, Nirav R. Bhakta, Juan Carlos Cardet, Mario Castro, et al. "Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations." American Journal of Respiratory and Critical Care Medicine 195, no. 3 (February 2017): 302–13. https://doi.org/10.1164/rccm.201602-0419OC.
  • Dunn, R. M., P. J. Busse, and M. E. Wechsler. "Asthma in the Elderly and Late-Onset Adult Asthma." Allergy 73, no. 2 (2018): 284–94. https://doi.org/10.1111/all.13258.
  • Duvall, Melody G., Nandini Krishnamoorthy, and Bruce D. Levy. "Non-Type 2 Inflammation in Severe Asthma Is Propelled by Neutrophil Cytoplasts and Maintained by Defective Resolution." Allergology International 68, no. 2 (April 1, 2019): 143–49. https://doi.org/10.1016/j.alit.2018.11.006.
  • Eberl, Gérard, Marco Colonna, James P. Di Santo, and Andrew N.J. McKenzie. "Innate Lymphoid Cells: A New Paradigm in Immunology." Science (New York, N.Y.) 348, no. 6237 (May 22, 2015): aaa6566. https://doi.org/10.1126/science.aaa6566.
  • Esteban-Gorgojo, Ignacio, Darío Antolín-Amérigo, Javier Domínguez-Ortega, and Santiago Quirce. "Non-Eosinophilic Asthma: Current Perspectives." Journal of Asthma and Allergy, October 29, 2018. https://doi.org/10.2147/JAA.S153097.
  • "Exercise-Induced Bronchoconstriction- ClinicalKey." Accessed October 2, 2019. https://www-clinicalkey-com.proxy.medlib.uits.iu.edu/#!/content/playContent/1-s2.0-S0889856118300079?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0889856118300079%3Fshowall%3Dtrue&referrer=https:%2F%2Fwww.ncbi.nlm.nih.gov%2F.
  • Fahy, John V. "Type 2 Inflammation in Asthma — Present in Most, Absent in Many." Nature Reviews Immunology 15, no. 1 (January 2015): 57–65. https://doi.org/10.1038/nri3786.
  • Fajt, Merritt L., and Sally E. Wenzel. "Asthma Phenotypes and the Use of Biologic Medications in Asthma and Allergic Disease: The next Steps toward Personalized Care." Journal of Allergy and Clinical Immunology 135, no. 2 (February 2015): 299–310. https://doi.org/10.1016/j.jaci.2014.12.1871.
  • Ferreira, Manuel A.R., Rick Jansen, Gonneke Willemsen, Brenda Penninx, Lisa M. Bain, Cristina T. Vicente, Joana A. Revez, et al. "Gene-Based Analysis of Regulatory Variants Identifies 4 Putative Novel Asthma Risk Genes Related to Nucleotide Synthesis and Signaling." Journal of Allergy and Clinical Immunology 139, no. 4 (April 2017): 1148–57. https://doi.org/10.1016/j.jaci.2016.07.017.
  • Friedman-Jimenez, George, Denise Harrison, and Honghong Luo. "Occupational Asthma and Work-Exacerbated Asthma." Seminars in Respiratory and Critical Care Medicine 36, no. 03 (June 2015): 388–407. https://doi.org/10.1055/s-0035-1550157.
  • Froidure, Antoine, Jonathan Mouthuy, Stephen R. Durham, Pascal Chanez, Yves Sibille, and Charles Pilette. "Asthma Phenotypes and IgE Responses." European Respiratory Journal 47, no. 1 (January 2016): 304–19. https://doi.org/10.1183/13993003.01824-2014.
  • Fuseini, Hubaida, and Dawn C. Newcomb. "Mechanisms Driving Gender Differences in Asthma." Current Allergy and Asthma Reports 17, no. 3 (March 2017): 19. https://doi.org/10.1007/s11882-017-0686-1.
  • Gibson, P. G., A. Girgis-Gabardo, M. M. Morris, S. Mattoli, J. M. Kay, J. Dolovich, J. Denburg, and F. E. Hargreave. "Cellular Characteristics of Sputum from Patients with Asthma and Chronic Bronchitis." Thorax 44, no. 9 (September 1989): 693–99. https://doi.org/10.1136/thx.44.9.693.
  • Hekking, Pieter-Paul W., Reinier R. Wener, Marijke Amelink, Aelko H. Zwinderman, Marcel L. Bouvy, and Elisabeth H. Bel. "The Prevalence of Severe Refractory Asthma." Journal of Allergy and Clinical Immunology 135, no. 4 (April 2015): 896–902. https://doi.org/10.1016/j.jaci.2014.08.042.
  • Hirano, Tsunahiko, and Kazuto Matsunaga. "Late-Onset Asthma: Current Perspectives." Journal of Asthma and Allergy 11 (February 9, 2018): 19–27. https://doi.org/10.2147/JAA.S125948.
  • Holgate, Stephen T., Sally Wenzel, Dirkje S. Postma, Scott T. Weiss, Harald Renz, and Peter D. Sly. "Asthma." Nature Reviews Disease Primers 1, no. 1 (September 10, 2015): 1–22. https://doi.org/10.1038/nrdp.2015.25.
  • Hondowicz, Brian D., Dowon An, Jason M. Schenkel, Karen S. Kim, Holly R. Steach, Akshay T. Krishnamurty, Gladys J. Keitany, et al. "Interleukin-2-Dependent Allergen-Specific Tissue-Resident Memory Cells Drive Asthma." Immunity 44, no. 1 (January 2016): 155–66. https://doi.org/10.1016/j.immuni.2015.11.004.
  • "Innate Immunity and Asthma Risk." New England Journal of Medicine 375, no. 19 (November 10, 2016): 1897–99. https://doi.org/10.1056/NEJMc1611699.
  • Jameson, J. Larry, ed. Harrison's Principles of Internal Medicine. Twentieth edition. New York: McGraw-Hill Education, 2018.
  • Kasper, Dennis L., Stephen Hauser L., Larry Jameson J., Anthony S. Fauci, Dan Longo L., and Joseph Loscalzo. Harrison's Principles of Internal Medicine. 19th ed. McGraw-Hill Education, 2015.
  • Khalaf, Kareem, Giovanni Paoletti, Francesca Puggioni, Francesca Racca, Fabrizio De Luca, Veronica Giorgis, Giorgio Walter Canonica, and Enrico Heffler. "Asthma from Immune Pathogenesis to Precision Medicine." Seminars in Immunology, August 2019, 101294. https://doi.org/10.1016/j.smim.2019.101294.
  • Kim, Harold, Anne K. Ellis, David Fischer, Mary Noseworthy, Ron Olivenstein, Kenneth R. Chapman, and Jason Lee. "Asthma Biomarkers in the Age of Biologics." Allergy, Asthma & Clinical Immunology 13, no. 1 (November 17, 2017): 48. https://doi.org/10.1186/s13223-017-0219-4.
  • King, Gregory G., Alan James, Louise Harkness, and Peter A. B. Wark. "Pathophysiology of Severe Asthma: We've Only Just Started." Respirology 23, no. 3 (2018): 262–71. https://doi.org/10.1111/resp.13251.
  • Kuruvilla, Merin E., F. Eun-Hyung Lee, and Gerald B. Lee. "Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease." Clinical Reviews in Allergy & Immunology 56, no. 2 (April 2019): 219–33. https://doi.org/10.1007/s12016-018-8712-1.
  • Lambrecht, Bart N, and Hamida Hammad. "The Immunology of Asthma." Nature Immunology 16, no. 1 (January 2015): 45–56. https://doi.org/10.1038/ni.3049.
  • Lambrecht, Bart N., Hamida Hammad, and John V. Fahy. "The Cytokines of Asthma." Immunity 50, no. 4 (April 16, 2019): 975–91. https://doi.org/10.1016/j.immuni.2019.03.018.
  • Lambrecht, Bart N., Emma K. Persson, and Hamida Hammad. "Myeloid Cells in Asthma." Microbiology Spectrum 5, no. 1 (February 1, 2017). https://doi.org/10.1128/microbiolspec.MCHD-0053-2016.
  • Loftus, Patricia A., and Sarah K. Wise. "Epidemiology of Asthma:" Current Opinion in Otolaryngology & Head and Neck Surgery 24, no. 3 (June 2016): 245–49. https://doi.org/10.1097/MOO.0000000000000262.
  • Lötvall, Jan, Cezmi A. Akdis, Leonard B. Bacharier, Leif Bjermer, Thomas B. Casale, Adnan Custovic, Robert F. Lemanske, Andrew J. Wardlaw, Sally E. Wenzel, and Paul A. Greenberger. "Asthma Endotypes: A New Approach to Classification of Disease Entities within the Asthma Syndrome." Journal of Allergy and Clinical Immunology 127, no. 2 (February 1, 2011): 355–60. https://doi.org/10.1016/j.jaci.2010.11.037.
  • McBrien, Claire N., and Andrew Menzies-Gow. "The Biology of Eosinophils and Their Role in Asthma." Frontiers in Medicine 4 (2017). https://doi.org/10.3389/fmed.2017.00093.
  • McDowell, P. Jane, and Liam G. Heaney. "Different Endotypes and Phenotypes Drive the Heterogeneity in Severe Asthma." Allergy, August 4, 2019. https://doi.org/10.1111/all.13966.
  • Mims, James W. "Asthma: Definitions and Pathophysiology." International Forum of Allergy & Rhinology 5, no. S1 (2015): S2–6. https://doi.org/10.1002/alr.21609.
  • Muc, Magdalena, Anabela Mota-Pinto, and Cristina Padez. "Association between Obesity and Asthma – Epidemiology, Pathophysiology and Clinical Profile." Nutrition Research Reviews 29, no. 2 (December 2016): 194–201. https://doi.org/10.1017/S0954422416000111.
  • Ntontsi, Polyxeni, Stelios Loukides, Petros Bakakos, Konstantinos Kostikas, Georgios Papatheodorou, Evgenia Ppathanassiou, Anastasia Papaporfyriou, et al. "Clinical, Functional and Inflammatory Characteristics in Patients with Paucigranulocytic Asthma." European Respiratory Journal 48, no. suppl 60 (September 1, 2016): PA4173. https://doi.org/10.1183/13993003.congress-2016.PA4173.
  • Pavord, Ian D, Richard Beasley, Alvar Agusti, Gary P Anderson, Elisabeth Bel, Guy Brusselle, Adnan Custovic, et al. "After Asthma – Redefining Airways Diseases. A Lancet Commission," n.d., 99.
  • Peters, Ubong, Anne E. Dixon, and Erick Forno. "Obesity and Asthma." Journal of Allergy and Clinical Immunology 141, no. 4 (April 2018): 1169–79. https://doi.org/10.1016/j.jaci.2018.02.004.
  • "Proinflammatory Pathways in the Pathogenesis of Asthma- ClinicalKey." Accessed October 2, 2019. https://www-clinicalkey-com.proxy.medlib.uits.iu.edu/#!/content/playContent/1-s2.0-S0272523118301254?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0272523118301254%3Fshowall%3Dtrue&referrer=https:%2F%2Fwww.ncbi.nlm.nih.gov%2F.
  • Quirce, Santiago, Paloma Campo, Javier Domínguez-Ortega, Mar Fernández-Nieto, Elisa Gómez-Torrijos, Ana Martínez-Arcediano, Pilar Mur, and Julio Delgado. "New Developments in Work-Related Asthma." Expert Review of Clinical Immunology 13, no. 3 (March 4, 2017): 271–81. https://doi.org/10.1080/1744666X.2017.1239529.
  • Ray, Anuradha, and Jay K. Kolls. "Neutrophilic Inflammation in Asthma and Association with Disease Severity." Trends in Immunology 38, no. 12 (December 2017): 942–54. https://doi.org/10.1016/j.it.2017.07.003.
  • Ray, Anuradha, Mahesh Raundhal, Timothy B. Oriss, Prabir Ray, and Sally E. Wenzel. "Current Concepts of Severe Asthma." Journal of Clinical Investigation 126, no. 7 (July 1, 2016): 2394–2403. https://doi.org/10.1172/JCI84144.
  • Robinson, D., M. Humbert, R. Buhl, A. A. Cruz, H. Inoue, S. Korom, N. A. Hanania, and P. Nair. "Revisiting Type 2-High and Type 2-Low Airway Inflammation in Asthma: Current Knowledge and Therapeutic Implications." Clinical & Experimental Allergy 47, no. 2 (2017): 161–75. https://doi.org/10.1111/cea.12880.
  • ———. "Revisiting Type 2-High and Type 2-Low Airway Inflammation in Asthma: Current Knowledge and Therapeutic Implications." Clinical & Experimental Allergy 47, no. 2 (2017): 161–75. https://doi.org/10.1111/cea.12880.
  • Rosen, Yale. Asthma. [object HTMLTableCellElement]. https://www.flickr.com/photos/pulmonary_pathology/3705143121/. https://commons.wikimedia.org/wiki/File:Asthma_.jpg.
  • Sakula, A. "Charcot-Leyden Crystals and Curschmann Spirals in Asthmatic Sputum." Thorax 41, no. 7 (July 1986): 503–7.
  • Seys, Sven F., Ravi Lokwani, Jodie L. Simpson, and Dominique M.A. Bullens. "New Insights in Neutrophilic Asthma:" Current Opinion in Pulmonary Medicine 25, no. 1 (January 2019): 113–20. https://doi.org/10.1097/MCP.0000000000000543.
  • Snelgrove, R. J., D. F. Patel, T. Patel, and C. M. Lloyd. "The Enigmatic Role of the Neutrophil in Asthma: Friend, Foe or Indifferent?" Clinical & Experimental Allergy 48, no. 10 (2018): 1275–85. https://doi.org/10.1111/cea.13191.
  • "Three Major Efforts to Phenotype Asthma: Severe Asthma Research Program, Asthma Disease Endotyping for Personalized Therapeutics, and Unbiased Biomarkers for the Prediction of Respiratory Disease Outcome- ClinicalKey." Accessed September 30, 2019. https://www-clinicalkey-com.proxy.medlib.uits.iu.edu/#!/content/playContent/1-s2.0-S0272523118301278.
  • Tliba, Omar, and Reynold A. Panettieri. "Paucigranulocytic Asthma: Uncoupling of Airway Obstruction from Inflammation." Journal of Allergy and Clinical Immunology 143, no. 4 (April 1, 2019): 1287–94. https://doi.org/10.1016/j.jaci.2018.06.008.
  • Trejo Bittar, Humberto E., Samuel A. Yousem, and Sally E. Wenzel. "Pathobiology of Severe Asthma." Annual Review of Pathology: Mechanisms of Disease 10, no. 1 (January 24, 2015): 511–45. https://doi.org/10.1146/annurev-pathol-012414-040343.
  • Weinberger, Steven E., Barbara A. Cockrill, and Jess Mandel. "Asthma." In Principles of Pulmonary Medicine, 7th ed., 75–92. Philadelphia, PA: Elsevier, 2019. http://www.clinicalkey.com/#!/content/book/3-s2.0-B9780323523714000088.
  • Yang, Ivana V., Catherine A. Lozupone, and David A. Schwartz. "The Environment, Epigenome, and Asthma." Journal of Allergy and Clinical Immunology 140, no. 1 (July 2017): 14–23. https://doi.org/10.1016/j.jaci.2017.05.011.
  • Yang, Xu, Haining Li, Qianli Ma, Qiao Zhang, and Changzheng Wang. "Neutrophilic Asthma Is Associated with Increased Airway Bacterial Burden and Disordered Community Composition." BioMed Research International 2018 (July 9, 2018): 1–11. https://doi.org/10.1155/2018/9230234.

Related Tutorials